Treatment for Concussions

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
ImPACT Applications, Inc., Coralville, IA
Concussions
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help researchers understand how well the ImPACT concussion-monitoring tool works on touchscreen devices, which could help more people get access to concussion screening. This trial is testing a new treatment for concussions. All patients in the trial will receive the active treatment, not a placebo.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Concussions

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 12 months

12 months
Validity
Day 60
Reliability

Trial Safety

Safety Progress

1 of 3

Other trials for Concussions

Trial Design

0 Treatment Group

900 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months
Closest Location: ImPACT Applications, Inc. · Coralville, IA
Photo of iowa 1Photo of iowa 2Photo of iowa 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Concussions
0 CompletedClinical Trials

Who is running the clinical trial?

ImPACT Applications, Inc.Lead Sponsor
3 Previous Clinical Trials
2,800 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.